Total Funding
35
Total FundingSeries A raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
308252
Arrien Pharmaceuticals is a small molecule-targeted therapeutics drug discovery and development company targeting cell signaling pathways.
Rajendra P. Appalaneni: Founder, Chairman & CEO
About the Company
Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. The Arrien is applying its proprietary platform to successfully discover a portfolio of uniquely
identified pre-clinical stage programs in Parkinson's, Alzheimer's Diseases (PD, AD), Cancer, Rheumatoid Arthritis (RA), Type 2 Diabetes and Obesity diseases.
